Is darunavir a blocking drug?

Darunavir (Darunavir) is not a blocking drug. It is an antiviral drug that belongs to the human immunodeficiency virus (HIV) protease inhibitor class and is used to treat patients who are already infected with HIV.

Blocking drugs usually refer to drugs used to preventHIV infection. They can be used in scenarios such as post-exposure prophylaxis (PEP) or pre-exposure prophylaxis (PrEP) to help uninfected people reduce the risk of exposure to HIV. These drugs reduce the risk of HIV infection through different mechanisms, such as preventing the virus from entering host cells or inhibiting virus replication within host cells.

Darunavir is a drug used to treat patients infected with HIV. By inhibiting the activity of HIV protease, it prevents the virus from replicating and multiplying in host cells, thereby slowing down viral replication, maintaining immune system function, and delaying the progression of HIV infection.

Darunavir is often used in combination with Ritonavir (Ritonavir). This combination is called "darunavir/Ritonavir enhanced" therapy, which can increase the concentration and duration of darunavir in the body, thereby enhancing its efficacy. This combination therapy is often used as part of antiretroviral therapy (ART) to control HIV infection, reduce viral load, maintain immune system function, and slow disease progression.

If you would like more information about blockers or antiretroviral drugs, talk to your professional health care provider or doctor.

Darunavir is currently on the market in China, but it has not yet been included in medical insurance. Patients can buy it at domestic pharmacies at a price of 2000It’s about RMB 1,000. Please consult the local hospital pharmacy for details. The cheaper ones abroad are Indian generic drugs, which cost around 320 yuan, and the ingredients of original drugs and generic drugs are basically the same.